Drugs in R & D

, Volume 2, Issue 5, pp 352–352 | Cite as


Section 2: HIV Fusion Inhibitor Adis R&D Profile


Zidovudine Pink Sheet Peptide Drug Reverse Trans Adis Comment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Barbouche R, Fenouillet E, Papandreou MJ, et al. Properties of HIV envelope expressed in the presence of SPC3, an Env-derived peptide drug under phase II clinical trials. J Peptide Res 1998 Oct; 52: 283–8CrossRefGoogle Scholar
  2. 2.
    Columbia Labs AIDS therapy SPC3 entering phase II/III clinicals. FDC Reports (Pink Sheet) 1995 Feb 27Google Scholar

Copyright information

© Adis International Limited 1999

Personalised recommendations